Healthcare M&A
In this age of innovation, collaboration, and disruption, the healthcare industry offers robust growth opportunities. Priorities like improved quality of care, better financial outcomes, and streamlined operational efficiencies are top of mind.
That’s why it’s important to have a competent law firm by your side. Whether you are looking to buy, sell, affiliate or invest, we can help you evaluate partnership structures, benefits, and risks associated with critical strategic transactions.
We canvassed CEOs, CFOs, and other professionals involved in M&A activities with their respective firms to gauge their insights and perspectives on the M&A market in the coming 12 months.
The results provide a snapshot of the M&A market and the economy this year and how they compare from previous years.
Dykema’s healthcare transactions team combines years of experience with deep industry knowledge. This powerful combination allows us to provide legal counsel within a rich context of what it takes to be successful in this rapidly evolving industry.
The team is a highly specialized group of attorneys, with a focus on getting transactions done. As the industry consolidates, both vertically and horizontally, Dykema is an industry leader in middle-market healthcare transactions. We have handled hundreds of buy- and sell-side transactions involving single office acquisitions, group formations, and large multi-office platforms. Each transaction is unique, and we take the time to understand how our clients define success so we can bring the right resources to any size deal.
“Structure, Regulation, and the Second Bite (ft. Craig Woods and Dean Gould, Dykema)”
What can healthcare organizations do today to better position themselves for a future transaction?…
Bill Introduced To Establish New Federal Corporate Practice of Medicine Restrictions
On September 16, 2026, the Stop Corporate Takeovers of Physicians Act was introduced in the U.S.…
Strategic Options and Alternatives
Eric White and Virgil Ochoa will present at the Healthcare Capital Markets & Innovation…
